(Q81535940)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584139%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

review article

1 reference

title

[Anti-TNF biologics in the treatment of chronic inflammatory bowel disease] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584139%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

9 January 2020

main subject

1 reference

S Nikolaus

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584139%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

S Schreiber

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584139%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 August 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584139%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584139%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584139%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584139%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

947-8, 950-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584139%20AND%20SRC:MED&resulttype=core&format=json

Genetics and inflammatory bowel disease.

9 January 2020

cites work

1 reference

12 December 2020

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.

1 reference

12 December 2020

Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease

1 reference

12 December 2020

Anti-TNF agents in Crohn's disease

1 reference

12 December 2020

Pregnancy and breastfeeding in patients with Crohn's disease

1 reference

12 December 2020

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

1 reference

12 December 2020

Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patients

1 reference

12 December 2020

Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial.

1 reference

12 December 2020

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

12 December 2020

Infliximab for induction and maintenance therapy for ulcerative colitis

1 reference

12 December 2020

Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open-label, multicentre trial

1 reference

12 December 2020

Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease

1 reference

12 December 2020

Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

1 reference

12 December 2020

Adalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: an open-label study

1 reference

12 December 2020

Certolizumab pegol for the treatment of Crohn's disease

1 reference

12 December 2020

Infliximab for treatment of resistant pyoderma gangrenosum associated with Crohn's disease

1 reference

12 December 2020

Maintenance therapy with certolizumab pegol for Crohn's disease

1 reference

12 December 2020

Infliximab in the treatment of extra-intestinal manifestations of Crohn's disease.

1 reference

12 December 2020

Infliximab for the treatment of fistulas in patients with Crohn's disease

1 reference

12 December 2020

Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial

1 reference

12 December 2020

Natalizumab Induction and Maintenance Therapy for Crohn's Disease

1 reference

12 December 2020

Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial

1 reference

12 December 2020

Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial

1 reference

12 December 2020

Review article: treatment of perianal fistulizing Crohn's disease

1 reference

12 December 2020

10.1007/S00108-008-2058-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584139%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference